Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Electromed, Inc.

ELMDAMEX
Healthcare
Medical - Devices
$24.12
$0.00(0.00%)
U.S. Market is Open • 15:53

Electromed, Inc. Fundamental Analysis

Electromed, Inc. (ELMD) shows strong financial fundamentals with a PE ratio of 22.56, profit margin of 13.06%, and ROE of 20.28%. The company generates $0.1B in annual revenue with strong year-over-year growth of 16.97%.

Key Strengths

ROE20.28%
Current Ratio4.86

Areas of Concern

PEG Ratio2.19
We analyze ELMD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 78.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
78.4/100

We analyze ELMD's fundamental strength across five key dimensions:

Efficiency Score

Excellent

ELMD demonstrates superior asset utilization.

ROA > 10%
16.38%

Valuation Score

Moderate

ELMD shows balanced valuation metrics.

PE < 25
22.56
PEG Ratio < 2
2.19

Growth Score

Excellent

ELMD delivers strong and consistent growth momentum.

Revenue Growth > 5%
16.97%
EPS Growth > 10%
50.00%

Financial Health Score

Excellent

ELMD maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.86

Profitability Score

Moderate

ELMD maintains healthy but balanced margins.

ROE > 15%
20.28%
Net Margin ≥ 15%
13.06%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ELMD Expensive or Cheap?

P/E Ratio

ELMD trades at 22.56 times earnings. This indicates a fair valuation.

22.56

PEG Ratio

When adjusting for growth, ELMD's PEG of 2.19 indicates potential overvaluation.

2.19

Price to Book

The market values Electromed, Inc. at 4.46 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.46

EV/EBITDA

Enterprise value stands at 17.12 times EBITDA. This signals the market has high growth expectations.

17.12

How Well Does ELMD Make Money?

Net Profit Margin

For every $100 in sales, Electromed, Inc. keeps $13.06 as profit after all expenses.

13.06%

Operating Margin

Core operations generate 16.66 in profit for every $100 in revenue, before interest and taxes.

16.66%

ROE

Management delivers $20.28 in profit for every $100 of shareholder equity.

20.28%

ROA

Electromed, Inc. generates $16.38 in profit for every $100 in assets, demonstrating efficient asset deployment.

16.38%

Following the Money - Real Cash Generation

Operating Cash Flow

Electromed, Inc. produces operating cash flow of $9.21M, showing steady but balanced cash generation.

$9.21M

Free Cash Flow

Electromed, Inc. generates strong free cash flow of $9.29M, providing ample flexibility for dividends, buybacks, or growth.

$9.29M

FCF Per Share

Each share generates $1.11 in free cash annually.

$1.11

FCF Yield

ELMD converts 4.54% of its market value into free cash.

4.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

22.56

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.19

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.97

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.86

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.20

vs 25 benchmark

ROA

Return on assets percentage

0.16

vs 25 benchmark

ROCE

Return on capital employed

0.25

vs 25 benchmark

How ELMD Stacks Against Its Sector Peers

MetricELMD ValueSector AveragePerformance
P/E Ratio22.5629.43 Better (Cheaper)
ROE20.28%800.00% Weak
Net Margin13.06%-20145.00% (disorted) Strong
Debt/Equity0.000.30 Strong (Low Leverage)
Current Ratio4.864.64 Strong Liquidity
ROA16.38%-17936.00% (disorted) Strong

ELMD outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Electromed, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

98.72%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

82.62%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

173.75%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ